Literature DB >> 47482

Relation of thyroid-stimulating immunoglobulins to thyroid function and effects of surgery, radioiodine, and antithyroid drugs.

E D Mukhtar, B R Smith, G A Pyle, R Hall, P Vice.   

Abstract

Thyroid-stimulating immunoglobulins (T.S.I.) have been detected in the serum of all patients with untreated Graves' disease, and in these patients the levels of T.S.I. correlated significantly with the early uptake of 131I by the thyroid. The frequency of T.S.I. in patients treated solely by antithyroid drugs, by radioiodine, or by partial thyroidectomy was 53 per cent, 50 per cent, and 17 per cent, respectively. The reduced frequency of T.S.I. in the serum of patients treated by drugs or radioiodine was probably due to spontaneous remission, but in the case of partial thyroidectomy the operation itself clearly had a dramatic effect on the serum-T.S;I. These results accorded well with the reported frequency of thyroid autonomy in similar groups of patients and suggested that thyroid-stimulating immunoglobulins were responsible for hyperthyroidism in Graves' disease.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47482     DOI: 10.1016/s0140-6736(75)91629-3

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  37 in total

1.  Editorial: hyperthyroidism and Grave's disease.

Authors: 
Journal:  Br Med J       Date:  1975-05-31

2.  Clinical course and thyroid stimulating hormone (TSH) receptor antibodies during surgical treatment of Graves' disease.

Authors:  Y Mori; N Matoba; S Miura; N Sakai; Y Taira
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

3.  Radio-receptor assay of TSH: its use to detect thyroid-stimulating immunoglobulins.

Authors:  G Fenzi; E Macchia; L Bartalena; F Mazzanti; L Baschieri; L J DeGroot
Journal:  J Endocrinol Invest       Date:  1978-01       Impact factor: 4.256

4.  TSH-receptor antibodies, HLA B8 and thyroid autoantibodies in patients with Graves' disease in therapeutically induced euthyroidism.

Authors:  G Schernthaner; H Ludwig; H Schleusener; R Finke; P Kotulla; W R Mayr
Journal:  Experientia       Date:  1979-10-15

5.  Determination of thyroid stimulating immunoglobulins (TSI) during the course of Graves' disease. A reliable indicator for remission and persistence of this disease?

Authors:  H Schleusener; R Finke; P Kotulla; K W Wenzel; H Meinhold; H D Roedler
Journal:  J Endocrinol Invest       Date:  1978-04       Impact factor: 4.256

6.  Iron-transport characteristics of vesicles of brush-border and basolateral plasma membrane from the rat enterocyte.

Authors:  E J Eastham; J I Bell; A P Douglas
Journal:  Biochem J       Date:  1977-05-15       Impact factor: 3.857

7.  Effects of autoantibodies to the insulin receptor on isolated adipocytes. Studies of insulin binding and insulin action.

Authors:  C R Kahn; K Baird; J S Filier; D B Jarrett
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

8.  Changes in thyrotropin binding inhibiting immunoglobulins (TBII) in sera of patients with Graves' disease at the time of relapse or exacerbation.

Authors:  H Uchimura; N Akimoto; T Mitsuhashi; K Kubota; N Kuzuya; Y Imai; H Ikeda; F Matsuzaki; L F Kumagai
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

9.  Prognostic value of thyroid stimulating antibodies and TSH-binding inhibiting immunoglobulins in the follow-up of Graves' disease.

Authors:  R Hörmann; B Saller; R Müller; K Mann
Journal:  Klin Wochenschr       Date:  1985-12-16

10.  Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.

Authors:  W A Valente; Z Yavin; E Yavin; E F Grollman; M Schneider; C M Rotella; R Zonefrati; R S Toccafondi; L D Kohn
Journal:  J Endocrinol Invest       Date:  1982 Sep-Oct       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.